Nevertheless, recent studies have described HE4 as a specific and useful biomarker for early diagnosis of epithelial ovarian cancer (EOC), which account for 90 % of all ovarian cancers [19]. The gene discussed is WFDC2; the disease is ovarian carcinoma.